Search
for
Sort by
Research 181–210 of 474
- Lupus erythematosus: systemic and cutaneous manifestations
- What causes hidradenitis suppurativa ?—15 years after
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- SUMMARIES OF PAPERS
- Westwood Carolina Conference on Clinical Dermatology
- Tolerability of hair cleansing conditioners: a double-blind randomized, controlled trial designed to evaluate consumer complaints to the U.S. Food and Drug Administration
- Metabolic and pathologic profiles of human LSS deficiency recapitulated in mice
- Biomechanical Factors in Psoriatic Disease: Defective Repair Exertion as a Potential Cause. Hypothesis Presentation and Literature Review
- Lupus erythematosus tumidus (LET) with autoimmune thyroid dysfunction (AITD) as the first presentation of systemic lupus erythematosus: A case report and review of the literature
- BI35 A case of dupilumab-induced scalp psoriasis and review of the literature
- Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
- Epidermal Vascular Endothelial Growth Factor Production Is Required for Permeability Barrier Homeostasis, Dermal Angiogenesis, and the Development of Epidermal Hyperplasia
- Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome
- Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
- Cutaneous manifestations associated with immune checkpoint inhibitors
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review
- Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction?
- Ichthyosis follicularis alopecia and photophobia syndrome:Transient improvement with oral isotretinoin
- Mycosis Fungoides in Elderly Adults—A Diagnostic Challenge
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Gut microbiota-derived metabolites in keloid and hypertrophic scarring
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management
- Adnexotropic Variants of the Interface Dermatitides: A Review
- Lipid-based nanoformulation optimization for achieving cutaneous targeting: Niosomes as the potential candidates to fulfill this aim
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Neurobiology, Stem Cell Biology, and Immunology: An Emerging Triad for Understanding Tissue Homeostasis and Repair